We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-9.7%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.22B
AUM Growth
-$882M
(-42%)
Cap. Flow
-$698M
Cap. Flow
% of AUM
-57.3%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
87
New
26
Increased
14
Reduced
19
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$50.4M |
| 2 |
AbbVie
ABBV
|
+$47.5M |
| 3 |
Heron Therapeutics
HRTX
|
+$46.7M |
| 4 |
Cardinal Health
CAH
|
+$45.6M |
| 5 |
Becton Dickinson
BDX
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$73.8M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$67.8M |
| 3 |
Zimmer Biomet
ZBH
|
+$66.3M |
| 4 |
Gilead Sciences
GILD
|
+$55.2M |
| 5 |
AGN
Allergan plc
AGN
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.43% |
| 2 | Technology | 3.14% |
| 3 | Consumer Discretionary | 1.97% |
| 4 | Industrials | 0.46% |
| 5 | Utilities | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zai Lab
ZLAB
$2.62B
| $4.34M | 0.36% |
+84,387
| New | +$4.4M |
|
52
Shopify
SHOP
$195B
| $3.94M | 0.32% |
+94,540
| New | +$4.26M |
|
53
Insmed
INSM
$28.6B
| $3.67M | 0.3% |
+228,781
| New | +$5.42M |
|
54
NextEra Energy
NEE
$177B
| $3.21M | 0.26% |
+53,280
| New | +$3.35M |
|
|
COUP
55
DELISTED
Coupa Software Incorporated
COUP
| $2.92M | 0.24% |
20,909
+11,178
| +115% | +$1.73M |
|
|
MYOK
56
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.67M | 0.14% |
+35,592
| New | +$2.28M |
|
|
ACOR
57
DELISTED
Acorda Therapeutics
ACOR
| $1.42M | 0.12% |
12,718
-3,060
| -19% | -$602K |
|
|
ALNA
58
DELISTED
Allena Pharmaceuticals
ALNA
| $274K | 0.02% |
+284,285
| New | +$569K |
|
59
Abbott
ABT
$187B
| – | – |
-322,713
| Closed | -$28M |
|
|
AMRN
60
Amarin Corp
AMRN
$303M
| – | – |
-26,671
| Closed | -$11.4M |
|
61
CALL
Biogen
BIIB
$30.7B
| – | – |
-30,300
| Closed | -$8.99M |
|
|
BPMC
62
PUT
DELISTED
Blueprint Medicines
BPMC
| – | – |
-336,800
| Closed | -$27M |
|
63
CALL
Cigna
CI
$74.6B
| – | – |
-519,500
| Closed | -$106M |
|
64
Salesforce
CRM
$158B
| – | – |
-63,398
| Closed | -$10.3M |
|
|
EXAS
65
DELISTED
Exact Sciences
EXAS
| – | – |
-209,839
| Closed | -$19.4M |
|
|
66
CALL
Gilead Sciences
GILD
$165B
| – | – |
-3,024,200
| Closed | -$197M |
|
67
Intuit
INTU
$89B
| – | – |
-16,747
| Closed | -$4.39M |
|
68
Microchip Technology
MCHP
$46B
| – | – |
-163,342
| Closed | -$8.55M |
|
69
Novartis
NVS
$297B
| – | – |
-442,640
| Closed | -$40.7M |
|
70
Envista
NVST
$4.52B
| – | – |
-825,732
| Closed | -$24.5M |
|
71
NXP Semiconductors
NXPI
$60.4B
| – | – |
-62,249
| Closed | -$7.92M |
|
72
PayPal
PYPL
$50.5B
| – | – |
-19,076
| Closed | -$2.06M |
|
73
Visteon
VC
$2.78B
| – | – |
-20,313
| Closed | -$1.76M |
|
74
CALL
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-126,200
| Closed | -$27.6M |
|
|
75
Zimmer Biomet
ZBH
$18.4B
| – | – |
-455,906
| Closed | -$66.3M |
|
Similar funds
DAM
MAM
DAM
KCM
MIA
YL
SL
PWA
PFM Health Sciences's Q1 2020 Portfolio in Review
As of Q1 2020, PFM Health Sciences held 87 positions worth $1.22B, down 42% from $2.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
PFM Health Sciences withdrew a net $698M in Q1 2020, closing 26 positions and reducing 19 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $73.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PFM Health Sciences opened a new position in McKesson worth $46.5M.
- PFM Health Sciences's largest Q1 2020 buy was McKesson: 343,950 shares worth $46.5M.
- PFM Health Sciences added most to AbbVie in Q1 2020, an estimated $47.5M increase.
- PFM Health Sciences's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $55.2M.
- PFM Health Sciences fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $73.8M.
- PFM Health Sciences's ten largest holdings make up 37% of its $1.22B portfolio in Q1 2020.
- PFM Health Sciences opened 26 new positions and closed 26 in Q1 2020.
- PFM Health Sciences's portfolio value fell 42% quarter-over-quarter to $1.22B.
Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.